Raman Probe for Bronchial Premalignant Lesions

用于支气管癌前病变的拉曼探头

基本信息

  • 批准号:
    7328885
  • 负责人:
  • 金额:
    $ 39.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-03-06 至 2009-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The goal of this program is to improve the diagnostic sensitivity and especially the specificity of autofluorescence endoscopes by examining additional information on the molecular constituents of the tissue being observed as determined by a fiberoptic Raman probe. The combined instrument will first use autofluorescence imaging to quickly identify areas of tissue which are likely to be dysplastic or cancerous. In a standard bronchoscopy procedure a small sample of tissue from this area would be taken with forceps passed through the narrow biopsy channel of the endoscope. In this program, a fiberoptic Raman probe will first be passed through this biopsy channel and pressed lightly against the suspect area of tissue. A 1-second pulse of narrowband, 830 nm light will be directed onto the tissue through a central fiber and lens assembly at the distal tip of the probe. A long-pass filter in the tip of the probe will block the backscattered 830 nm excitation wavelength but pass the longer wavelength tissue fluorescence and Raman-shifted light into a ring of collection fibers. These collection fibers will carry the scattered light back to a spectrometer which will disperse it into a characteristic Raman "fingerprint" spectrum. This spectrum contains many individual peaks corresponding to the concentration of specific molecules in the tissue. The standard biopsy will then be taken from the tissue site and sent to a pathology lab to be examined for evidence of dysplasia or cancer. This program will catalog the measured spectra and correlate them with the results of pathology. Once the catalog of spectra contains samples of normal, dysplastic and cancerous tissue fingerprints it will be possible to begin to predict, in real-time, what the results of pathology will be. A large number of spectra will need to be collected, however, from many different stages of discovered cancers before the predicted results are likely to be reliable. The use of autofluorescence imaging during bronchoscopy procedures has been shown to improve the sensitivity of cancer diagnosis over that which can be achieved by white light observation alone. This means there are few instances where a truly cancerous or dysplastic area of tissue is seen to be normal (a false negative determination of cancer). On the other hand, the method often classifies normal tissue as cancerous (a false positive determination) which leads to an additional risk to the patient from unnecessary biopsies, wasted time during the procedure and additional costs. The additional information from the Raman probe is expected to be able to identify many of these false positive sites as truly normal, increasing the specificity of the tissue characterization. Once the method is proven to be effective it will reduce patient risk, reduce the time required for procedures and reduce the cost of unnecessary biopsies.
描述(由申请人提供):该计划的目标是通过检查由光纤拉曼探针确定的所观察组织的分子成分的附加信息来提高诊断灵敏度,尤其是自发荧光内窥镜的特异性。该组合仪器将首先使用自发荧光成像来快速识别可能发育不良或癌变的组织区域。在标准支气管镜检查程序中,将使用穿过内窥镜狭窄活检通道的镊子从该区域采集少量组织样本。在此程序中,光纤拉曼探头将首先穿过该活检通道并轻轻按压可疑的组织区域。 1 秒窄带 830 nm 光脉冲将通过探头远端的中心光纤和透镜组件引导到组织上。探头尖端的长通滤光片将阻挡反向散射的 830 nm 激发波长,但将较长波长的组织荧光和拉曼位移光传递到收集光纤环中。这些收集纤维将散射光带回光谱仪,光谱仪将其分散成特征拉曼“指纹”光谱。该光谱包含许多与组织中特定分子浓度相对应的单独峰。然后将从组织部位进行标准活检并送往病理实验室检查是否存在发育不良或癌症的证据。该程序将对测量的光谱进行分类,并将其与病理结果相关联。一旦光谱目录包含正常、发育异常和癌组织指纹样本,就有可能开始实时预测病理结果。然而,在预测结果可能可靠之前,需要从已发现的癌症的许多不同阶段收集大量光谱。与单独通过白光观察相比,在支气管镜检查过程中使用自发荧光成像已被证明可以提高癌症诊断的灵敏度。这意味着很少有真正癌变或发育不良的组织区域被视为正常的情况(癌症的假阴性判定)。另一方面,该方法经常将正常组织归类为癌性组织(假阳性确定),这会给患者带来额外的风险,包括不必要的活检、手术过程中浪费的时间和额外的费用。来自拉曼探针的附加信息预计能够将许多假阳性位点识别为真正正常的位点,从而提高组织表征的特异性。一旦该方法被证明是有效的,它将降低患者的风险,减少手术所需的时间,并减少不必要的活检的成本。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEPHEN FREDERICK FULGHUM其他文献

STEPHEN FREDERICK FULGHUM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEPHEN FREDERICK FULGHUM', 18)}}的其他基金

Raman spectroscopy probes for assisting stereotactic breast biopsy needle placeme
拉曼光谱探针辅助立体定向乳腺活检针放置
  • 批准号:
    7746180
  • 财政年份:
    2009
  • 资助金额:
    $ 39.58万
  • 项目类别:
Non-Contact Spectroscopic Probe For Endoscope
内窥镜非接触式光谱探头
  • 批准号:
    7405043
  • 财政年份:
    2008
  • 资助金额:
    $ 39.58万
  • 项目类别:
Raman Probe for Bronchial Premalignant Lesions
用于支气管癌前病变的拉曼探头
  • 批准号:
    7053922
  • 财政年份:
    2006
  • 资助金额:
    $ 39.58万
  • 项目类别:
Raman Probe for Bronchial Premalignant Lesions
用于支气管癌前病变的拉曼探头
  • 批准号:
    7477805
  • 财政年份:
    2006
  • 资助金额:
    $ 39.58万
  • 项目类别:
Clinical System for Arterial Tissue Characterization
动脉组织表征的临床系统
  • 批准号:
    6736538
  • 财政年份:
    2004
  • 资助金额:
    $ 39.58万
  • 项目类别:
Clinical System for Arterial Characterization
动脉表征临床系统
  • 批准号:
    6998136
  • 财政年份:
    2003
  • 资助金额:
    $ 39.58万
  • 项目类别:
Clinical System for Arterial Characterization
动脉表征临床系统
  • 批准号:
    7117186
  • 财政年份:
    2003
  • 资助金额:
    $ 39.58万
  • 项目类别:
Spectroscopic Diagnostic for Barrett's Dysplasia
巴雷特发育不良的光谱诊断
  • 批准号:
    6666929
  • 财政年份:
    1999
  • 资助金额:
    $ 39.58万
  • 项目类别:
SPECTROSCOPIC DIAGNOSTIC FOR BARRETTS DYSPLASIA
Barrett 发育不良的光谱诊断
  • 批准号:
    2867971
  • 财政年份:
    1999
  • 资助金额:
    $ 39.58万
  • 项目类别:
Spectroscopic Diagnostic for Barrett's Dysplasia
巴雷特发育不良的光谱诊断
  • 批准号:
    6583122
  • 财政年份:
    1999
  • 资助金额:
    $ 39.58万
  • 项目类别:

相似国自然基金

基于IL-17免疫微环境研究纳米中药对动脉斑块巨噬细胞区域免疫的调控
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    51 万元
  • 项目类别:
    面上项目
LCN2介导反应性星形胶质细胞极化表型变化参与区域性动脉内低温治疗缺血性卒中的分子机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
多模态影像深度学习指导狭窄主动脉瓣纤维化/钙化区域化分布的规律及机制研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    24 万元
  • 项目类别:
    青年科学基金项目
基于多模态影像学的视乳头区域微循环灌注评估及NAION发病机制研究
  • 批准号:
    81800840
  • 批准年份:
    2018
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Neural Operator Learning to Predict Aneurysmal Growth and Outcomes
神经算子学习预测动脉瘤的生长和结果
  • 批准号:
    10636358
  • 财政年份:
    2023
  • 资助金额:
    $ 39.58万
  • 项目类别:
Transcranial Ultrasound Algorithms and Device for Rapid Stroke Determination by Paramedics
用于医护人员快速确定中风的经颅超声算法和设备
  • 批准号:
    10730722
  • 财政年份:
    2023
  • 资助金额:
    $ 39.58万
  • 项目类别:
AI-based Cardiac CT
基于人工智能的心脏CT
  • 批准号:
    10654259
  • 财政年份:
    2023
  • 资助金额:
    $ 39.58万
  • 项目类别:
Broad Bandwidth Transducers for High Resolution Information Rich IVUS
宽带宽传感器可提供高分辨率信息丰富的 IVUS
  • 批准号:
    10447462
  • 财政年份:
    2022
  • 资助金额:
    $ 39.58万
  • 项目类别:
Broad Bandwidth Transducers for High Resolution Information Rich IVUS
宽带宽传感器可提供高分辨率信息丰富的 IVUS
  • 批准号:
    10642851
  • 财政年份:
    2022
  • 资助金额:
    $ 39.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了